EcoR1 Capital, LLC Quant / Systematic

Location: San Francisco, CA

CIK: 0001587114 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $563M (100.0% shares, 0.0% debt)

Holdings (36)

ALEXION PHARMACEUTICALS, INC 13.9%
Value $78.22M Shares 569,500 Est. Cost Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 12.6%
Value $70.87M Shares 3,753,635 Est. Cost $10.60 Unrealized +37.1%
ASSEMBLY BIOSCIENCES INC 10.8%
Value $60.78M Shares 2,943,164 Est. Cost $8.38 Unrealized
FIBROGEN INC 9.1%
Value $51.21M Shares 1,585,457 Est. Cost $32.10 Unrealized
GLPG GALAPAGOS NV SPON ADR 7.9%
Value $44.27M Shares 578,505 Est. Cost $58.59 Unrealized
ASND ASCENDIS PHARMA A S 7.3%
Value $41.16M Shares 1,482,600 Est. Cost $22.80 Unrealized
GILEAD SCIENCES INC 6.8%
Value $38.05M Shares 500,000 Est. Cost Unrealized
SGMO SANGAMO BIOSCIENCES INC 4.0%
Value $22.6M Shares 2,568,119 Est. Cost $6.42 Unrealized 0.0%
KURA KURA ONCOLOGY INC COM 3.4%
Value $18.91M Shares 2,033,622 Est. Cost $10.12 Unrealized -10.1%
TOCAGEN INC 3.2%
Value $18.07M Shares 1,502,373 Est. Cost $12.03 Unrealized
CTMX CYTOMX THERAPEUTICS INC 2.2%
Value $12.32M Shares 794,969 Est. Cost $13.16 Unrealized +14.5%
EDIT EDITAS MEDICINE INC COM 2.1%
Value $12.03M Shares 717,107 Est. Cost $18.02 Unrealized 0.0%
CASCADIAN THERAPEUTICS INC 2.0%
Value $11.14M Shares 3,000,000 Est. Cost $4.14 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 1.7%
Value $9.741M Shares 805,000 Est. Cost $10.68 Unrealized 0.0%
VERTEX PHARMACEUTICALS INC 1.6%
Value $9.109M Shares 60,000 Est. Cost Unrealized
FATE FATE THERAPEUTICS INC 1.5%
Value $8.22M Shares 2,537,026 Est. Cost $3.66 Unrealized +4.7%
ATYR PHARMA INC 1.4%
Value $7.795M Shares 2,292,659 Est. Cost $2.92 Unrealized
OVASCIENCE INC 1.0%
Value $5.479M Shares 3,512,332 Est. Cost $1.87 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.9%
Value $5.03M Shares 185,472 Est. Cost $26.78 Unrealized +1.5%
KINDRED BIOSCIENCES INC 0.8%
Value $4.686M Shares 544,880 Est. Cost $7.10 Unrealized
TETRAPHASE PHARMACEUTICALS INC 0.8%
Value $4.516M Shares 633,400 Est. Cost $7.13 Unrealized
EDITAS MEDICINE INC COM 0.8%
Value $4.315M Shares 255,000 Est. Cost Unrealized
REGULUS THERAPEUTICS INC 0.6%
Value $3.656M Shares 3,709,144 Est. Cost $1.26 Unrealized
ACHILLION PHARMACEUTICALS INC 0.6%
Value $3.41M Shares 742,835 Est. Cost $4.59 Unrealized
NABRIVA THERAPEUTICS 0.5%
Value $2.775M Shares 264,773 Est. Cost $10.48 Unrealized
DICERNA PHARMACEUTICALS INC 0.4%
Value $2.435M Shares 767,992 Est. Cost $3.28 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.4%
Value $2.186M Shares 874,447 Est. Cost $4.11 Unrealized
MINERVA NEUROSCIENCES INC 0.4%
Value $1.981M Shares 223,802 Est. Cost $8.85 Unrealized
BIOHAVEN PHARMACEUTICAL HLDG CO LTD 0.3%
Value $1.75M Shares 70,000 Est. Cost $25.00 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value $1.199M Shares 23,300 Est. Cost $43.55 Unrealized +17.4%
CHEMOCENTRYX INC 0.2%
Value $1.104M Shares 118,000 Est. Cost $7.28 Unrealized
BMY BRISTOL MYERS SQUIBB CO 0.2%
Value $951K Shares 17,060 Est. Cost $39.73 Unrealized +0.4%
CLOVIS ONCOLOGY INC 0.2%
Value $936K Shares 10,000 Est. Cost $93.60 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.1%
Value $831K Shares 10,425 Est. Cost $63.91 Unrealized 0.0%
SEATTLE GENETICS INC 0.1%
Value $776K Shares 15,000 Est. Cost $51.73 Unrealized
ARATANA THERAPEUTICS INC 0.1%
Value $723K Shares 100,000 Est. Cost $7.23 Unrealized